Market Place
Sourcing Support
Angelini pens $360M biobucks pact for ph. 1 brain disorder drug
21 Oct 2024 //
FIERCE BIOTECH
Angelini Pharma Licenses Brain Health Asset From Cureverse
21 Oct 2024 //
GLOBENEWSWIRE
Helsinn and Angelini Pharma renew distribution deal
28 May 2024 //
PHARMACEUTICAL TECHNOLOGY
Helsinn Angelini Aulin® Mesulid®: Partnership Renewal In Select Countries
27 May 2024 //
GLOBENEWSWIRE
Approval provided for Angelini’s cenobamate
16 May 2023 //
PHARMATIMES
Italy`s Angelini invests up to $506 mln in Japan`s JCR for epilepsy drug
12 May 2023 //
REUTERS
SK Biopharmaceuticals` Partner Angelini Pharma Launches Cenobamate in France
08 Dec 2022 //
PRNEWSWIRE
Cenobamate is Now Available in France and Belgium
07 Dec 2022 //
BUSINESSWIRE
Angelini Industries appoints Jacopo Andreose new CEO of Angelini Pharma
22 Nov 2022 //
PRESS RELEASE
Cenobamate for the Treatment of Drug-Resistant Focal-Onset Seizures in Adults
01 Apr 2022 //
BUSINESSWIRE
Angelini Pharma, a New Partner in Epilepsy
25 Mar 2022 //
BUSINESSWIRE
Angelini Pharma, a new partner in Epilepsy
14 Feb 2022 //
BUSINESSWIRE
Angelini Pharma and Lumira launch the Angelini Lumira Biosciences Fund (ALBF)
28 Jul 2021 //
GLOBENEWSWIRE
Angelini Pharma and Lumira launch the Angelini Lumira Biosciences Fund (ALBF)
28 Jul 2021 //
GLOBENEWSWIRE
EC approval for Ontozry
06 Apr 2021 //
PHARMATIMES
EC grants marketing authorisation to Angelini Pharma’s epilepsy treatment
01 Apr 2021 //
PHARMAFILE
EC grants marketing authorisation to Angelini Pharma’s epilepsy treatment
31 Mar 2021 //
PHARMAFILE
Angelini acquires Arvelle to create a leading European innovator in CNS
14 Jan 2021 //
PRNEWSWIRE
Angelini Pharma acquires Arvelle Therapeutics
04 Jan 2021 //
PRESS RELEASE
Angelini Pharma and Sunovion Europe receive EMA approval for Latuda
13 Nov 2020 //
PRNEWSWIRE
Corvus Pharmaceuticals Announces Co-Founding of Angel Pharmaceuticals in China
06 Oct 2020 //
CORVUS PHARMA
Angelini lands EU rights to Ovid`s phase 3 rare disease drug
14 Jul 2020 //
FIERCE BIOTECH
Rosita Calabrese is the new Country Manager Italy
02 Jul 2020 //
PRESS RELEASE
Enza Onnis, Global Pharma General Counsel at Angelini Pharma
15 Apr 2020 //
PRESS RELEASE
Andrè Kindling, new Country Manager Germany
14 Apr 2020 //
PRESS RELEASE
EC grants marketing authorisation to Angelini Pharma’s epilepsy treatment
05 Apr 2020 //
PHARMAFILE
Angelini Foundation in support of Lazzaro Spallanzani Hospital in the fight against Coronavirus
23 Mar 2020 //
PRESS RELEASE
Angelini Pharma on the front lines against COVID-19
20 Mar 2020 //
PRESS RELEASE
Angelini Pharma, Inc. U.S. Launches First Infection Prevention Portfolio
20 Mar 2020 //
PR NEWSWIRE
Angelini Pharma Acquires ThermaCare® From GSK
10 Mar 2020 //
PR NEWSWIRE
Angelini Pharma acquires ThermaCare from GSK
07 Mar 2020 //
HOYCICLISMO
Roberto Lombardo joins Angelini Pharma as Pharma Chief Human Resources
04 Mar 2020 //
PRESS RELEASE
Daniela Poggio Global Communications Head at Angelini Pharma
10 Feb 2020 //
PRESS RELEASE
Fabio De Luca Chief Marketing Officer at Angelini Pharma
07 Feb 2020 //
PRESS RELEASE
Angelini Announces close of acquisition of two Sanofi (CHC) products
29 Aug 2019 //
PRESS RELEASE
Sumitomo Dainippon & Angelini announce partnership for commercialization Latuda
29 Aug 2017 //
PRESS RELEASE
Angelini To Launch New Disinfectant Wipe That Is Effective Against Clostridium Difficile
09 Feb 2017 //
CLEANROOM
Keneric Healthcare and Angelini Pharma Partner in the U.S. Wound Care Market
24 Jan 2017 //
PR NEWSWIRE
Angelini Fine Chemicals: new synthesis technologies to broaden the offer
01 Nov 2016 //
PRESS RELEASE
Actavis Sued Over Generic Oleptro Plans
23 Aug 2016 //
LAW
corporate welfare of ACRAF Angelini
05 Jul 2016 //
SECONDO WELFARE
Angelini confirms commitment in Infection Control and Infectious Diseases Area
18 Apr 2016 //
PRESS RELEASE
India woos Italian bulk drug makers to cut dependency on Chinese APIs
13 Aug 2015 //
THE ECONOMIC TIMES
